J. Kerr

909 total citations · 1 hit paper
12 papers, 670 citations indexed

About

J. Kerr is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J. Kerr has authored 12 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in J. Kerr's work include Cancer Treatment and Pharmacology (6 papers), Multiple Myeloma Research and Treatments (2 papers) and HER2/EGFR in Cancer Research (2 papers). J. Kerr is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Multiple Myeloma Research and Treatments (2 papers) and HER2/EGFR in Cancer Research (2 papers). J. Kerr collaborates with scholars based in United States, United Kingdom and Canada. J. Kerr's co-authors include Hazel Hayhurst, Arnd Barocka, R. Ramana, Zafra Cooper, Eugene S. Paykel, Mark S. Walker, Lee S. Schwartzberg, Edward J. Stepanski, Yeun Mi Yim and Arthur C. Houts and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

J. Kerr

11 papers receiving 630 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Residual symptoms after partial remission: an important outcome in depression

1995 628 citations Eugene S. Paykel, R. Ramana et al. Psychological Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Kerr United States	5	417	311	274	121	99	12	670
Emma Wright United Kingdom	7	178 0.4×	246 0.8×	180 0.7×	231 1.9×	85 0.9×	9	624
Meridith A. Rankin United States	6	196 0.5×	184 0.6×	312 1.1×	185 1.5×	66 0.7×	6	673
Yasmin Mahal United States	6	182 0.4×	157 0.5×	149 0.5×	96 0.8×	78 0.8×	6	469
Outi Poutanen Finland	15	173 0.4×	154 0.5×	252 0.9×	323 2.7×	144 1.5×	27	798
Grace Morris Australia	17	224 0.5×	117 0.4×	466 1.7×	183 1.5×	67 0.7×	36	787
Enrico Zanalda Italy	11	110 0.3×	165 0.5×	140 0.5×	166 1.4×	59 0.6×	20	467
Quynh-Van Tran United States	16	311 0.7×	104 0.3×	448 1.6×	63 0.5×	56 0.6×	20	689
Jill Gonzales United States	14	251 0.6×	185 0.6×	412 1.5×	190 1.6×	35 0.4×	17	824
Ahsan Y. Khan United States	10	154 0.4×	124 0.4×	188 0.7×	59 0.5×	35 0.4×	25	467
Charles South United States	12	133 0.3×	139 0.4×	98 0.4×	120 1.0×	58 0.6×	24	458

Countries citing papers authored by J. Kerr

Since Specialization

Citations

This map shows the geographic impact of J. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kerr more than expected).

Fields of papers citing papers by J. Kerr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kerr. The network helps show where J. Kerr may publish in the future.

Co-authorship network of co-authors of J. Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of J. Kerr. A scholar is included among the top collaborators of J. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Kerr. J. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Copher, Ronda, Debanjana Chatterjee, Prashant Joshi, et al.. (2018). Treatment patterns and effectiveness outcomes in patients with stage IV, renal cell carcinoma.. Journal of Clinical Oncology. 36(15_suppl). e16571–e16571. 1 indexed citations

2.

Walshe, Janice M., Giuseppe Gullo, John Kennedy, et al.. (2018). Abstract OT3-06-05: A phase Ib/II trial of coPANlisib in combination with tratuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”. Cancer Research. 78(4_Supplement). OT3–6. 1 indexed citations

3.

Walker, Mark S., Ze Cong, Kevin Knopf, et al.. (2015). Real world impact of treatment-induced peripheral neuropathy (TIPN) on patient reported outcomes (PROs) in patients with multiple myeloma (MM) in the United States.. Journal of Clinical Oncology. 33(15_suppl). e19531–e19531. 3 indexed citations

4.

Walker, Mark S., Anthony Masaquel, J. Kerr, et al.. (2014). Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden. Breast Cancer Research and Treatment. 144(3). 673–681. 8 indexed citations

5.

Walker, Mark S., Carolina Reyes, J. Kerr, Sacha Satram‐Hoang, & Edward J. Stepanski. (2014). Treatment patterns and outcomes among patients with metastatic melanoma treated in community practice. International Journal of Dermatology. 53(11). e499–506. 5 indexed citations

6.

Martin, Thomas G., Sumeet Panjabi, J. Kerr, Michael G. Martin, & Mark S. Walker. (2013). Association Of Treatment Induced Peripheral Neuropathy (TIPN) With Treatment Patterns and Outcomes In Patients (pts) With Newly Diagnosed Multiple Myeloma (NDMM). Blood. 122(21). 1750–1750. 1 indexed citations

7.

Walker, Mark S., Anthony Masaquel, J. Kerr, et al.. (2013). Real-world symptom burden and early treatment discontinuation in first-line metastatic breast cancer (MBC).. Journal of Clinical Oncology. 31(15_suppl). 9619–9619.

8.

Walker, Mark S., et al.. (2012). Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancer. BMC Research Notes. 5(1). 314–314. 15 indexed citations

9.

Engel, J., Renate Eckel, J. Kerr, et al.. (2003). The process of metastasization for breast cancer. The Breast. 12. S21–S21. 1 indexed citations

10.

Simmonds, P.D., Graham M. Mead, John Sweetenham, et al.. (1997). PACE BOM chemotherapy: A 12-week regimen for advanced Hodgkin’s disease. Annals of Oncology. 8(3). 259–266. 4 indexed citations

11.

Paykel, Eugene S., R. Ramana, Zafra Cooper, et al.. (1995). Residual symptoms after partial remission: an important outcome in depression. Psychological Medicine. 25(6). 1171–1180. 628 indexed citations breakdown →

12.

Stanford, Matthew S., et al.. (1994). The Rorschach and Personality Classifications of the California Psychological Inventory. Perceptual and Motor Skills. 78(1). 142–142. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact